Next Article in Journal
Development and Characterization of Novel Combinations and Compositions of Nanostructured Lipid Carrier Formulations Loaded with Trans-Resveratrol for Pulmonary Drug Delivery
Next Article in Special Issue
C24 Ceramide Lipid Nanoparticles for Skin Wound Healing
Previous Article in Journal
The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment
Previous Article in Special Issue
Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(12), 1588; https://doi.org/10.3390/pharmaceutics16121588
Action Date Notes Link
article pdf uploaded. 12 December 2024 16:06 CET Version of Record https://www.mdpi.com/1999-4923/16/12/1588/pdf-vor
article supplementary file uploaded. 12 December 2024 16:06 CET - https://www.mdpi.com/1999-4923/16/12/1588#supplementary
article xml file uploaded 14 December 2024 01:42 CET Original file -
article xml uploaded. 14 December 2024 01:42 CET Update https://www.mdpi.com/1999-4923/16/12/1588/xml
article pdf uploaded. 14 December 2024 01:42 CET Updated version of record https://www.mdpi.com/1999-4923/16/12/1588/pdf
article html file updated 14 December 2024 01:44 CET Original file https://www.mdpi.com/1999-4923/16/12/1588/html
Back to TopTop